Sagent Pharmaceuticals Confirms Data Breach Exposing 1,383 Records, Worldleaks Claims Responsibility

Sagent Pharmaceuticals, a specialty injectable drug maker headquartered in Schaumburg, IL, detected unauthorized access to its network in early February 2026. After engaging external cybersecurity firms, the company concluded its forensic review on March 23, 2026.

The breach affected 1,383 individuals, exposing driver’s licenses, full names, Social Security numbers, bank account details, state IDs and health‑insurance information. Worldleaks announced responsibility for the intrusion on the dark web on March 8, 2026. The initial compromise date is estimated as February 11, 2026, though the exact attack vector has not been publicly disclosed.

For the affected individuals, the exposed data increases risk of identity theft and financial fraud, prompting the class‑action law firm Shamis & Gentile P.A. to investigate potential compensation claims. For Sagent, the incident may trigger regulatory scrutiny under HIPAA and state data‑protection laws, as well as reputational damage.

Enforce multi‑factor authentication on all remote and privileged accounts to mitigate credential‑theft tactics (MITRE ATT&CK T1078). Apply the latest security patches for internet‑facing services, prioritizing known vulnerabilities listed in CVE databases that could allow initial access. Deploy network segmentation and monitor for anomalous login patterns or lateral movement using SIEM rules aligned with techniques such as T1059 (Command and Scripting Interpreter) and T1021 (Remote Services).